Coronary artery calcium progression: An important clinical measurement?

Journal of the American College of Cardiology

Volumn 56, Issue 20, 2010, Pages 1613-1622

  McEvoy, John W ^a   Blaha, Michael J ^a   DeFilippis, Andrew P ^a   Budoff, Matthew J ^b   Nasir, Khurram ^a,c   Blumenthal, Roger S ^a   Jones, Steven R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Cardiac CT; Coronary artery calcium; Progression; Review

Indexed keywords

ALPHA TOCOPHEROL; AMILORIDE; ASCORBIC ACID; ATORVASTATIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SEVELAMER; SIMVASTATIN; CALCIUM;

ADULT; CARDIOVASCULAR RISK; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTRON BEAM TOMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; RISK REDUCTION; ANGIOCARDIOGRAPHY; CALCINOSIS; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; HOSPITALIZATION; METABOLISM; POSITRON EMISSION TOMOGRAPHY;

CALCINOSIS; CALCIUM; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78751691043     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.06.038     Document Type: Review

References (78)

1. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295:1556-65.
2. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association Writing Group. Circulation 1996;94:1175-92. (Pubitemid 26292883)
3. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004;291:210 -5. (Pubitemid 38082815)
4. O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 2000;36:326-40. (Pubitemid 30466157)
5. Bostrom K. Insights into the mechanism of vascular calcification. Am J Cardiol 2001;88:20E-2E. (Pubitemid 32721979)
6. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15:1512-31.
7. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 1994;94:1597-604.
8. Van Campenhout A, Golledge J. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 2009;204:321-9.
9. Beckman JA, Ganz J, Creager MA, Ganz P, Kinlay S. Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol 2001;21:1618 -22. (Pubitemid 34215581)
10. Nadra I, Mason JC, Philippidis P, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ Res 2005;96:1248 -56. (Pubitemid 40962102)
11. Thomas JD, Zoghbi WA, Beller GA, et al. ACCF 2008 training statement on multimodality noninvasive cardiovascular imaging: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol 2009;53:125-46.
12. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32. (Pubitemid 20101575)
13. Callister TQ, Cooil B, Raya SP, Lippolis NJ, Russo DJ, Raggi P. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998;208: 807-14. (Pubitemid 28405121)
14. Hong C, Bae KT, Pilgram TK. Coronary artery calcium: accuracy and reproducibility of measurements with multi-detector row CT - assessment of effects of different thresholds and quantification methods. Radiology 2003;227:795-801. (Pubitemid 36583039)
15. Maher JE, Bielak LF, Raz JA, Sheedy PF II, Schwartz RS, Peyser PA. Progression of coronary artery calcification: a pilot study. Mayo Clin Proc 1999;74:347-55. (Pubitemid 29162534)
16. Schmermund A, Baumgart D, Mohlenkamp S, et al. Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: an electron-beam CT study. Arterioscler Thromb Vasc Biol 2001;21:421-6. (Pubitemid 32199125)
17. Budoff MJ, Lane KL, Bakhsheshi H, et al. Rates of progression of coronary calcium by electron beam tomography. Am J Cardiol 2000; 86:8 -11. (Pubitemid 30365135)
18. Hokanson JE, MacKenzie T, Kinney G, et al. Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am J Roentgenol 2004;182:1327-32. (Pubitemid 38525535)
19. Lu B, Budoff MJ, Zhuang N, et al. Causes of interscan variability of coronary artery calcium measurements at electron-beam CT. Acad Radiol 2002;9:654-61. (Pubitemid 34568800)
20. Bielak LF, Sheedy PF II, Peyser PA. Coronary artery calcification measured at electron-beam CT: agreement in dual scan runs and change over time. Radiology 2001;218:224 -9. (Pubitemid 32151299)
21. Mao S, Bakhsheshi H, Lu B, Liu SC, Oudiz RJ, Budoff MJ. Effect of electrocardiogram triggering on reproducibility of coronary artery calcium scoring. Radiology 2001;220:707-11. (Pubitemid 32799978)
22. Budoff MJ, Raggi P. Coronary artery disease progression assessed by electron-beam computed tomography. Am J Cardiol 2001;88: 46E-50E. (Pubitemid 32721986)
23. Detrano RC, Anderson M, Nelson J, et al. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility - MESA study. Radiology 2005;236:477-84. (Pubitemid 41023428)
24. Budoff MJ, Hokanson JE, Nasir K, et al. Progression of coronary artery calcium predicts all-cause mortality. J Am Coll Cardiol Img 2010. In press.
25. Budoff MJ, Mao S, Zalace CP, Bakhsheshi H, Oudiz RJ. Comparison of spiral and electron beam tomography in the evaluation of coronary calcification in asymptomatic persons. Int J Cardiol 2001;77:181-8. (Pubitemid 32155904)
26. Budoff MJ, McClelland RL, Chung H, et al. Reproducibility of coronary artery calcified plaque with cardiac 64-MDCT: the Multi- Ethnic Study of Atherosclerosis. AJR Am J Roentgenol 2009;192: 613-7.
27. Mao SS, Pal RS, McKay CR, et al. Comparison of coronary artery calcium scores between electron beam computed tomography and 64-multidetector computed tomographic scanner. J Comput Assist Tomogr 2009;33:175-8.
28. Lu B, Zhuang N, Mao SS, et al. EKG-triggered CT data acquisition to reduce variability in coronary arterial calcium score. Radiology 2002;224:838-44. (Pubitemid 34919822)
29. Kim KP, Einstein AJ, Berrington de Gonzalez A. Coronary artery calcification screening: estimated radiation dose and cancer risk. Arch Intern Med 2009;169:1188 -94.
30. Feldman W. How serious are the adverse effects of screening? J Gen Intern Med 1990;5 Suppl:S50 -3. (Pubitemid 20325613)
31. Horton KM, Post WS, Blumenthal RS, Fishman EK. Prevalence of significant noncardiac findings on electron-beam computed tomography coronary artery calcium screening examinations. Circulation 2002; 106:532-4. (Pubitemid 34827699)
32. Cassidy-Bushrow AE, Bielak LF, Sheedy PF II, et al. Coronary artery calcification progression is heritable. Circulation 2007;116:25-31. (Pubitemid 47016243)
33. Kramer CK, von Muhlen D, Gross JL, Barrett-Connor E. A prospective study of abdominal obesity and coronary artery calcium progression in older adults. J Clin Endocrinol Metab 2009;94:5039-44.
34. Kramer CK, von Muhlen D, Gross JL, Laughlin GA, Barrett-Connor E. Blood pressure and fasting plasma glucose rather than metabolic syndrome predict coronary artery calcium progression: the Rancho Bernardo Study. Diabetes Care 2009;32:141-6.
35. Lee KK, Fortmann SP, Fair JM, et al. Insulin resistance independently predicts the progression of coronary artery calcification. Am Heart J 2009;157:939-45.
36. Costacou T, Edmundowicz D, Prince C, Conway B, Orchard TJ. Progression of coronary artery calcium in type 1 diabetes mellitus. Am J Cardiol 2007;100:1543-7. (Pubitemid 350050857)
37. Anand DV, Lim E, Darko D, et al. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers. J Am Coll Cardiol 2007;50:2218 -25. (Pubitemid 350166815)
38. Elkeles RS, Godsland IF, Rubens MB, Feher MD, Nugara F, Flather MD. The progress of coronary heart disease in Type 2 diabetes as measured by coronary calcium score from electron beam computed tomography (EBCT): the PREDICT study. Atherosclerosis 2008; 197:777-83. (Pubitemid 351417876)
39. Kawakubo M, LaBree L, Xiang M, et al. Race-ethnic differences in the extent, prevalence, and progression of coronary calcium. Ethn Dis 2005;15:198 -204. (Pubitemid 40561637)
40. Berry JD, Liu K, Folsom AR, et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation 2009;119:382-9.
41. Kronmal RA, McClelland RL, Detrano R, et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007;115:2722-30. (Pubitemid 46842788)
42. Maahs DM, Ogden LG, Kretowski A, et al. Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes. Diabetes 2007;56:2774 -9. (Pubitemid 350044921)
43. Kretowski A, McFann K, Hokanson JE, et al. Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis. Diabetes 2007;56:863-71. (Pubitemid 46348466)
44. Maahs DM, Ogden LG, Kinney GL, et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 2005;111:747-53. (Pubitemid 40250635)
45. Yoon HC, Emerick AM, Hill JA, Gjertson DW, Goldin JG. Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects. Radiology 2002;224:236-41. (Pubitemid 34680400)
46. Min JK, Lin FY, Gidseg DS, et al. Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal? J Am Coll Cardiol 2010;55:1110 -7.
47. Gopal A, Nasir K, Liu ST, Flores FR, Chen L, Budoff MJ. Coronary calcium progression rates with a zero initial score by electron beam tomography. Int J Cardiol 2007;117:227-31. (Pubitemid 46454414)
48. Taylor AJ, Bindeman J, Le TP, et al. Progression of calcified coronary atherosclerosis: relationship to coronary risk factors and carotid intima-media thickness. Atherosclerosis 2008;197:339-45. (Pubitemid 351273256)
49. Rivera JJ, Nasir K, Katz R, et al. Relationship of thoracic aortic calcium to coronary calcium and its progression (from the Multi- Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 1 2009;103: 1562-7.
50. Azen SP, Mack WJ, Cashin-Hemphill L, et al. Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation 1996;93:34-41. (Pubitemid 26006565)
51. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 2005;46:158-65. (Pubitemid 40905145)
52. Veress AI, Cornhill JF, Herderick EE, Thomas JD. Age-related development of atherosclerotic plaque stress: a population-based finite-element analysis. Coron Artery Dis 1998;9:13-9. (Pubitemid 28200942)
53. Shemesh J, Apter S, Stolero D, Itzchak Y, Motro M. Annual progression of coronary artery calcium by spiral computed tomography in hypertensive patients without myocardial ischemia but with prominent atherosclerotic risk factors, in patients with previous angina pectoris or healed acute myocardial infarction, and in patients with coronary events during follow-up. Am J Cardiol 2001;87:1395-7. (Pubitemid 32523027)
54. Raggi P, Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol 2004;24: 1272-7. (Pubitemid 38880020)
55. Raggi P, Cooil B, Shaw LJ, et al. Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol 2003;92:827-9. (Pubitemid 37163579)
56. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998;339: 1972-8. (Pubitemid 29024129)
57. Budoff MJ, Yu D, Nasir K, et al. Diabetes and progression of coronary calcium under the influence of statin therapy. Am Heart J 2005;149: 695-700.
58. Achenbach S, Ropers D, Pohle K, et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation 2002;106:1077-82. (Pubitemid 34970847)
59. Hecht HS, Harman SM. Relation of aggressiveness of lipid-lowering treatment to changes in calcified plaque burden by electron beam tomography. Am J Cardiol 2003;92:334-6. (Pubitemid 36897727)
60. Houslay ES, Cowell SJ, Prescott RJ, et al. Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial. Heart 2006;92:1207-12. (Pubitemid 44298857)
61. Terry JG, Carr JJ, Kouba EO, et al. Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the Coronary Artery calcification Treatment with Zocor [CATZ] study). Am J Cardiol 2007;99:1714 -7. (Pubitemid 46874323)
62. Schmermund A, Achenbach S, Budde T, et al. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation 2006;113: 427-37. (Pubitemid 43803205)
63. Raggi P, Davidson M, Callister TQ, et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 2005;112:563-71. (Pubitemid 41060797)
64. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol 2005;46:166 -72. (Pubitemid 40905146)
65. Budoff MJ, Chen GP, Hunter CJ, et al. Effects of hormone replacement on progression of coronary calcium as measured by electron beam tomography. J Womens Health (Larchmt) 2005;14:410 -7. (Pubitemid 41052039)
66. Motro M, Shemesh J. Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension 2001;37:1410 -3. (Pubitemid 34225383)
67. Budoff MJ, Ahmadi N, Gul KM, et al. Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial. Prev Med 2009;49:101-7.
68. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-52. (Pubitemid 34754068)
69. Qunibi W, Moustafa M, Muenz LR, et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 2008;51:952-65. (Pubitemid 351697566)
70. Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006;48:438-45. (Pubitemid 44109954)
71. Sutton-Tyrrell K, Kuller LH, Edmundowicz D, et al. Usefulness of electron beam tomography to detect progression of coronary and aortic calcium in middle-aged women. Am J Cardiol 1 2001;87:560-4. (Pubitemid 32178450)
72. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
73. Stary HC. The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression. Am J Cardiol 2001;88:16E-9E. (Pubitemid 32721978)
74. Wu B, Elmariah S, Kaplan FS, Cheng G, Mohler ER III. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease. Arterioscler Thromb Vasc Biol 2005;25:592-7. (Pubitemid 40315683)
75. Burgstahler C, Reimann A, Beck T, et al. Influence of a lipid-lowering therapy on calcified and noncalcified coronary plaques monitored by multislice detector computed tomography: results of the New Age II Pilot Study. Invest Radiol 2007;42:189 -95. (Pubitemid 46232824)
76. Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010;375:735-42.
77. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9 Suppl:S16 -23.
78. Bursztyn M, Motro M, Grossman E, Shemesh J. Accelerated coronary artery calcification in mildly reduced renal function of high-risk hypertensives: a 3-year prospective observation. J Hypertens 2003;21: 1953-9. (Pubitemid 37290115)